- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05750407
Feasibility of Cardiovascular Health Intervention Within Evidence-based Home Visiting
August 19, 2024 updated by: Suzanne Phelan, California Polytechnic State University-San Luis Obispo
The purpose of this pilot study is to examine the feasibility and acceptability of brief lifestyle intervention modules designed to promote healthy eating, activity, and weight control for pregnant and postpartum clients receiving care as part of evidence-based home visiting.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this pilot study is to examine the feasibility and acceptability of brief lifestyle intervention modules designed to promote healthy eating, activity, and weight control behaviors for pregnant and postpartum clients receiving care as part of evidence-based home visiting.
A 6 week, pre-post test of evidence-based home visiting (usual care) plus three lifestyle intervention modules (eating, activity, tracking) will be conducted at two sites (California and Rhode Island).
Three, 10 minute intervention modules will target healthy eating, activity, and self-monitoring of weight and diet.
Pregnant and postpartum clients (N =20) in home visiting programs will be recruited over 2 months and evaluated at baseline and after 6 weeks.
Home visitors will participate in one training session and deliver the intervention content during three visits over 6 weeks.
Quantitative data from will inform feasibility of lifestyle intervention within evidence-based home visiting.
Findings will inform the cardiovascular health intervention and study protocol for a full scale trial.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Luis Obispo, California, United States, 93407
- Cal Poly
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Miriam Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- self-reported current participation in a home visiting program
- self-reported currently pregnant or postpartum less than or equal to 6 weeks
- English or Spanish speaking
Exclusion Criteria (based on self report):
- Age less than 18 years
- Lower than 5th grade reading level
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Evidence based home visiting with lifestyle modules
Three lifestyle change modules will be discussed with clients: healthy eating, activity, and tracking diet and weight
|
Three modules target healthy eating, activity, and weight control behaviors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived acceptability of treatment score
Time Frame: 6 week
|
Questionnaire
|
6 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in life's essential 8 total score
Time Frame: 6 weeks
|
Questionnaire
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2023
Primary Completion (Actual)
July 30, 2024
Study Completion (Actual)
July 30, 2024
Study Registration Dates
First Submitted
February 20, 2023
First Submitted That Met QC Criteria
February 20, 2023
First Posted (Actual)
March 1, 2023
Study Record Updates
Last Update Posted (Actual)
August 21, 2024
Last Update Submitted That Met QC Criteria
August 19, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-ENRICH Pilot
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.